本发明涉及一种抗动脉粥样血栓形成剂与抗血小板凝集剂的新组合产品。
The invention relates to a novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent.
具有降低脑血管阻力，改善脑血循环、增加脑血流量及抗血小板凝集的作用。
It can reduce cerebral vascular resistance, improve blood circulation, increase cerebral blood flow and has anti-platelet aggregation effect.
作用：具有降低脑血管阻力，改善脑学循环、增加脑学流量及抗血小板凝集的作用。
Function: It can reduce cerebral vascular resistance, improve blood circulation, increase cerebral blood flow and has an anti-plate aggregation effect.
茶多酚还具有抗血凝、促纤溶和抑制血小板凝集作用，对动脉粥样硬化的预防具有积极意义。
It also can prevent blood from coagulating, promote the dissolution of fibre and inhibit the agglutination of blood platelet, and play active role of preventing atherosclerosis.
但是有一个可能是血液替代品里面的血红蛋白分子夺取氧化一氮分子，这些分子一般发挥舒张血管和组织血小板凝集作用。
But one possibility is that hemoglobin molecules in substitute blood capture nitric oxide molecules that normally dilate blood vessels and keep platelets from getting sticky.
近年来，在缺血性中风的血液学检测方面，发现了血小板颗粒膜蛋白(GMP—140)在血小板活化、凝集过程中起着重要作用。
Recently, in hematological examination of ischemic stroke, we find Granular Membrane Protein-140 (GMP-140) plays a important role in platelet activating and agglutinating.
类似的结果也发生在人类富含血小板之血浆的凝集作用。
Similar results were observed in human platelet-rich plasma stimulated by agonists.
结论：abo不合的干细胞移植患者输血，应使用不被患者血清凝集素破坏的红细胞和不带有其它血清凝集素的血小板浓缩液。
Conclusion: RBCs and platelet with me not destroyed by the recipients' serum agglutinin were required for patients undergoing ABO incompatible allogenic stem cell transplantation.
结论：abo不合的干细胞移植患者输血，应使用不被患者血清凝集素破坏的红细胞和不带有其它血清凝集素的血小板浓缩液。
Conclusion: RBCs and platelet with me not destroyed by the recipients' serum agglutinin were required for patients undergoing ABO incompatible allogenic stem cell transplantation.
应用推荐